Related Experiment Video

Updated: Apr 28, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

7.9K

Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity

Mauricio Cabrera1, Macarena Simoens, Gabriela Falchi

  • 1Departamento de Química Orgánica, Facultad de Química-Facultad de Ciencias, Universidad de la República, 11400 Montevideo, Uruguay.

Bioorganic & Medicinal Chemistry
|March 27, 2007
PubMed

Insights

Synthetic chalcones, flavanones, and flavones were tested for antitumor activity. Chalcones showed the most promise, with several compounds demonstrating significant activity against kidney and colon cancer cells.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmacology

Background:

  • Synthetic chalcones, flavanones, and flavones are classes of compounds with potential biological activities.
  • Antitumor research is crucial for developing new cancer therapies.
  • Understanding structure-activity relationships aids in designing more effective drugs.

Purpose of the Study:

  • To synthesize and evaluate the antitumor potential of novel chalcone, flavanone, and flavone derivatives.
  • To identify lead compounds with significant activity against human kidney (TK-10), breast (MCF-7), and colon (HT-29) cancer cell lines.
  • To investigate the genotoxicity of active compounds using the comet assay and establish structure-activity relationships.

Main Methods:

  • Synthesis of chalcone, flavanone, and flavone libraries.
  • In vitro antitumor screening against TK-10, MCF-7, and HT-29 cell lines.
  • Alkaline single cell gel electrophoresis (comet assay) for genotoxicity assessment on normal human kidney cells (HK-2).
  • Structure-activity relationship (SAR) analysis.

Main Results:

  • Chalcones exhibited the most potent antitumor activity, particularly against TK-10 and HT-29 cells.
  • Fourteen out of 53 synthesized compounds demonstrated significant activity against at least two cancer cell lines.
  • Comet assay revealed genotoxic effects of some active chalcones on normal kidney cells.
  • A quantitative structure-activity relationship was established for anti-HT-29 activity, especially for 4- and 3,4-disubstituted derivatives.

Conclusions:

  • Chalcones represent a promising scaffold for developing novel anticancer agents.
  • Further optimization of chalcone derivatives is warranted to enhance efficacy and reduce potential genotoxicity.
  • Structure-activity relationship insights can guide the design of targeted antitumor therapies.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

863

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81